brain disorders
features of human brain development
specific cerebral organoids
brain disease burden
specific human disease models
used animal models
interconnected brain regions
animal use
developmental diseases
human mini brains
animal experiments
commercial feasibility of cerebral organoids
mini brainsâ€™
cost of drug development
development of therapies
proprietary human pluripotent stem cell
drug screening
humans
patient-specific stem cells
use of patient
conventional cell culture methods
D organoid culture system
rate of approved drugs
major pharmaceutical companies
petri dish
new possibilities
major bottleneck
high attrition rate of drugs
reliability of results
pharmaceutical research
unique opportunity
validation
alternative
costs
fundamental differences
physiological aspects
discovery
cost-effective tool
project
complexity
inherent limitations of current
potential
respective departments
aim